Kyowa Hakko Kirin

Results: 49



#Item
41Kyowa Hakko Kirin Co., Ltd. Consolidated Financial Summary FiscalJanuary 1, 2014 – December 31, 2014)

Kyowa Hakko Kirin Co., Ltd. Consolidated Financial Summary FiscalJanuary 1, 2014 – December 31, 2014)

Add to Reading List

Source URL: www.kyowa-kirin.com

Language: English - Date: 2015-01-30 00:40:12
    42Kyowa Hakko Kirin and Syndax Announce an Exclusive License Agreement to Develop and Commercialize Entinostat in Japan and Korea Tokyo, Japan, January 8, 2015 and Waltham, Mass., January 7, Kyowa Hakko Kirin Co.,

    Kyowa Hakko Kirin and Syndax Announce an Exclusive License Agreement to Develop and Commercialize Entinostat in Japan and Korea Tokyo, Japan, January 8, 2015 and Waltham, Mass., January 7, Kyowa Hakko Kirin Co.,

    Add to Reading List

    Source URL: www.kyowa-kirin.com

    Language: English - Date: 2015-01-07 19:00:05
      43Results Presentation Fiscal 2014 Interim (January 1, 2014 – June 30, 2014) Kyowa Hakko Kirin Co., Ltd. July 31, 2014

      Results Presentation Fiscal 2014 Interim (January 1, 2014 – June 30, 2014) Kyowa Hakko Kirin Co., Ltd. July 31, 2014

      Add to Reading List

      Source URL: www.kyowa-kirin.com

      Language: English - Date: 2014-07-30 01:40:12
        44Kyowa Hakko Kirin Co., Ltd. Consolidated Financial Summary Fiscal 2014, Third Quarter (January 1, 2014 – September 30, 2014)

        Kyowa Hakko Kirin Co., Ltd. Consolidated Financial Summary Fiscal 2014, Third Quarter (January 1, 2014 – September 30, 2014)

        Add to Reading List

        Source URL: www.kyowa-kirin.com

        Language: English - Date: 2014-10-28 00:40:09
          45Launch of Dovobet® Ointment Topical Combination Drug for Psoriasis Vulgaris Tokyo, Japan, September 11, Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; “Kyowa Hakk

          Launch of Dovobet® Ointment Topical Combination Drug for Psoriasis Vulgaris Tokyo, Japan, September 11, Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; “Kyowa Hakk

          Add to Reading List

          Source URL: www.kyowa-kirin.com

          Language: English - Date: 2014-09-11 01:00:04
            46FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer Corporate Commun

            FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer Corporate Commun

            Add to Reading List

            Source URL: www.kyowa-kirin.com

            Language: English - Date: 2015-02-17 02:40:04
              47ProStrakan completes acquisition of Archimedes 6th August, 2014 Galashiels, UK – ProStrakan Group plc (“ProStrakan”), a subsidiary of global specialty pharmaceutical company, Kyowa Hakko Kirin Co., Ltd. (“KHK”)

              ProStrakan completes acquisition of Archimedes 6th August, 2014 Galashiels, UK – ProStrakan Group plc (“ProStrakan”), a subsidiary of global specialty pharmaceutical company, Kyowa Hakko Kirin Co., Ltd. (“KHK”)

              Add to Reading List

              Source URL: www.prostrakan.com

              Language: English - Date: 2015-01-08 04:28:44
              48Kirin Holdings Company, Limited 2011 Annual Report It’s time for a good taste Kirin Holdings Company, Limited

              Kirin Holdings Company, Limited 2011 Annual Report It’s time for a good taste Kirin Holdings Company, Limited

              Add to Reading List

              Source URL: www.kirinholdings.co.jp

              Language: English - Date: 2012-05-06 21:00:04
              49PRESS RELEASE January 14, 2013, 8 a.m. Central European Time NOVALIX ENTERS INTO FRAGMENT-BASED DRUG DISCOVERY ALLIANCE WITH KYOWA HAKKO KIRIN Strasbourg, France, January 14, 2013/ b3c newswire

              PRESS RELEASE January 14, 2013, 8 a.m. Central European Time NOVALIX ENTERS INTO FRAGMENT-BASED DRUG DISCOVERY ALLIANCE WITH KYOWA HAKKO KIRIN Strasbourg, France, January 14, 2013/ b3c newswire

              Add to Reading List

              Source URL: www.graffinity.com

              Language: English - Date: 2013-03-21 04:51:08